Marcus Bosenberg

Active 1992–2025

134
Papers
27,639
Citations
87
h-index
126
i10-index

Citations

Citations per year for Marcus Bosenberg1991: 1 citations1992: 1 citations1993: 6 citations1994: 18 citations1995: 18 citations1996: 14 citations1997: 41 citations1998: 24 citations1999: 16 citations2000: 23 citations2001: 25 citations2002: 37 citations2003: 44 citations2004: 46 citations2005: 47 citations2006: 54 citations2007: 64 citations2008: 72 citations2009: 84 citations2010: 115 citations2011: 93 citations2012: 162 citations2013: 203 citations2014: 163 citations2015: 241 citations2016: 384 citations2017: 520 citations2018: 492 citations2019: 1,215 citations2020: 1,456 citations2021: 1,561 citations2022: 1,304 citations2023: 1,080 citations2024: 1,542 citations2025: 903 citations2026: 19 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,941 citing papers, 30.3% of this breakdownChina: 2,516 citing papers, 15.4% of this breakdownUnited Kingdom: 833 citing papers, 5.1% of this breakdownGermany: 829 citing papers, 5.1% of this breakdownFrance: 640 citing papers, 3.9% of this breakdownItaly: 633 citing papers, 3.9% of this breakdownAustralia: 440 citing papers, 2.7% of this breakdownSpain: 440 citing papers, 2.7% of this breakdownSwitzerland: 415 citing papers, 2.6% of this breakdownJapan: 399 citing papers, 2.5% of this breakdownCanada: 372 citing papers, 2.3% of this breakdownNetherlands: 361 citing papers, 2.2% of this breakdown
0%30.3%Other 21.3%

Fields

  • Biochemistry, Genetics and Molecular Biology40%
  • Medicine39.5%
  • Immunology and Microbiology15.7%
  • Neuroscience1.9%
  • Engineering1%
  • Computer Science0.5%
  • Other1.4%

Topics

  • Cancer Immunotherapy and Biomarkers7.6%
  • Immunotherapy and Immune Responses5.4%
  • Melanoma and MAPK Pathways4.2%
  • Immune Cell Function and Interaction3.9%
  • Immune cells in cancer3.8%
  • CAR-T cell therapy research3.3%
  • Other71.8%

Coauthors

All papers

Open in search
  1. Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

    Authors: , , , , , , , , , , , , , , , , , - Cell 2015 cited by 1,471

  2. Genomic Classification of Cutaneous Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marcus Bosenberg, Jay Bowen, Reanne Bowlby, Christopher A. Bristow, Laura Brockway-Lunardi, Denise Brooks, Jakub Brzezinski, Wiam Bshara, Elizabeth Buda, William R. Burns, Yaron S.N. Butterfield, M. Button, Tiffany L. Calderone, Giancarlo Antonini Cappellini, Candace Carter, Scott L. Carter, Lynn Cherney, Andrew D. Cherniack, Aaron Chevalier, Lynda Chin, Juok Cho, Raymond J. Cho, Yoon‐La Choi, Andy Chu, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Stephen W. Coons, Leslie Cope, Daniel Crain, Erin Curley, Ludmila Danilova, Stefania D’Atri, Tanja M. Davidsen, Michael A. Davies, Keith A. Delman, John A. Demchok, Qixia A. Deng, Yonathan Lissanu Deribe, Noreen Dhalla, Rajiv Dhir, Daniel DiCara, М С Диникин, Michael Dubina, J. Stephen Ebrom, Sophie Egea, Greg Eley, Jay Engel, Jennifer Eschbacher, Konstantin Fedosenko, Ina Felau, Timothy R. Fennell, Martin L. Ferguson, Sheila Fisher, Keith T. Flaherty, Scott Frazer, Jessica Frick, Victoria Fulidou, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Levi A. Garraway, Julie M. Gastier-Foster, Carmelo Gaudioso, Nils Gehlenborg, Giannicola Genovese, Mark Gerken, Jeffrey E. Gershenwald, Gad Getz and 252 more - Cell 2015 cited by 3,286

  3. Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , - Immunity 2016 cited by 1,169

  4. Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy P. Heffernan, Jianhua Hu, Roland L. Bassett, Marcus Bosenberg, Scott E. Woodman, Willem W. Overwijk, Gregory Lizée, Jason Roszik, Thomas F. Gajewski, Jennifer A. Wargo, Jeffrey E. Gershenwald, Laszlo Radvanyi, Michael A. Davies, Patrick Hwu - Cancer Discovery 2015 cited by 1,531

  5. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours

    Authors: , , , , , , , , - Nature 2020 cited by 528

  6. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy

    Authors: , , , , , , , , , , , , - Nature 2020 cited by 367

  7. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesca M. Bosisio, Panagiotis Karras, A. Hunter Shain, Marcus Bosenberg, Eleonora Leucci, Annette Paschen, Florian Rambow, Oliver Bechter, Jean‐Christophe Marine - Cell 2024 cited by 195

  8. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 266

  9. scFTD-seq: freeze-thaw lysis based, portable approach toward highly distributed single-cell 3′ mRNA profiling

    Authors: , , , , , , , - Nucleic Acids Research 2018 cited by 287

  10. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 340

  11. The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations

    Authors: , , , , - Pigment Cell & Melanoma Research 2016 cited by 324

  12. RETRACTED ARTICLE: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qin Liu, Edmund K. Bartlett, Giorgos C. Karakousis, Zeynep Eroglu, Roger S. Lo, Matthew Chan, Alexander M. Menzies, Georgina V. Long, Douglas B. Johnson, Jeffrey A. Sosman, Bastian Schilling, Dirk Schadendorf, David W. Speicher, Marcus Bosenberg, Antoni Ribas, Ashani T. Weeraratna - Nature 2016 cited by 390

  13. Manipulating mitochondrial electron flow enhances tumor immunogenicity

    Authors: , , , , , , , , , , , , , , , , , , , , - Science 2023 cited by 114

  14. Endogenous Glucocorticoid Signaling Regulates CD8+ T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , - Immunity 2020 cited by 228

  15. BrafV600E cooperates with Pten loss to induce metastatic melanoma

    Authors: , , , , , , , , , - Nature Genetics 2009 cited by 1,176

  16. Melanoma models for the next generation of therapies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard M. White, Iwei Yeh, Jiyue Zhu, Leonard I. Zon, Marc Hurlbert, Glenn Merlino - Cancer Cell 2021 cited by 227

  17. Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ira Mellman, Michael Karin, Shabnam Shalapour - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 99

  18. Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2019 cited by 232

  19. Autophagy maintains tumour growth through circulating arginine

    Authors: , , , , , , , , , , , , , , , , - Nature 2018 cited by 377

  20. Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting

    Authors: , , , , , , , , , , , - Cell Metabolism 2019 cited by 254

  21. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 120

  22. Therapy-induced tumour secretomes promote resistance and tumour progression

    Authors: , , , , , , , , , , , - Nature 2015 cited by 502

  23. The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression

    Authors: , , , , , , , , , , , , , , , , , , , - Immunity 2017 cited by 189

  24. Ferroptosis in colorectal cancer: a future target?

    Authors: , , , , - British Journal of Cancer 2023 cited by 110